Human equilibrative nucleoside transporter 1 (hENT1): Do we really have a new predictive biomarker of chemotherapy outcome in pancreatic cancer patients?

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F13%3A33145232" target="_blank" >RIV/61989592:15110/13:33145232 - isvavai.cz</a>

Result on the web

<a href="http://dx.doi.org/10.1016/j.pan.2013.09.005" target="_blank" >http://dx.doi.org/10.1016/j.pan.2013.09.005</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.pan.2013.09.005" target="_blank" >10.1016/j.pan.2013.09.005</a>

Result language

angličtina

Original language name

Human equilibrative nucleoside transporter 1 (hENT1): Do we really have a new predictive biomarker of chemotherapy outcome in pancreatic cancer patients?

Original language description

Although systemic chemotherapy significantly improves the overal survival of pancreatic cancer patients, the prognosis remains extremely poor. The development of a drug resistence, either de novo or induced resistence, significantly limits the effectiveness of chemotherapy.

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FD - Oncology and haematology

OECD FORD branch

—

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2013

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Pancreatology

ISSN

1424-3903

e-ISSN

—

Volume of the periodical

13

Issue of the periodical within the volume

4

Country of publishing house

CH - SWITZERLAND

Number of pages

6

Pages from-to

558-563

UT code for WoS article

—

EID of the result in the Scopus database

—